Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
GlobeNewswire
· Submissions supported by comprehensive analytical and clinical data package including a Phase I PK/PD similarity study and the..
· Submissions supported by comprehensive analytical and clinical data package including a Phase I PK/PD similarity study and the..
· Submission supported by comprehensive analytical and clinical data from new Phase I bridging pharmacokinetics study
·..